Spruce Biosciences (SPRB) Stock Rocketed 132% In Pre-market Session Friday, Why?

After announcing a strategic partnership, Spruce Biosciences Inc. (Nasdaq: SPRB) shares jumped 132.00% to $2.90 on Friday morning. What contract did SPRB announce? Spruce Biosciences (SPRB) disclosed that it and Kaken Pharmaceutical have signed an exclusive licensing deal. For the purpose of treating congenial adrenal hyperplasia (CAH) in Japan, Spruce Biosciences engaged in an agreement […]